Page URL:

Women with a family history of breast cancer should take preventative drugs, says NICE

21 January 2013
Appeared in BioNews 689

Women at high risk of developing breast cancer should be offered preventative drugs, says an updated draft guideline from the National Institute for Health and Clinical Excellence (NICE).

'This draft guideline represents a historic step for the prevention of breast cancer. It is the first time drugs have ever been recommended for reducing breast cancer risk in the UK', says chief executive of the charity Breakthrough Breast Cancer, Chris Askew.

In the UK, breast cancer affects approximately 50,000 women a year, with ten percent of cases being familial. Familial breast cancer refers to cases where there is a strong family history of the disease, suggesting a genetic predisposition. Some genetic mutations are known to significantly increase the risk of developing breast cancer, such as mutations in the BRCA1 and BRCA2 genes.

'It's wise for any person with a family history of cancer to receive appropriate investigations and screening that would otherwise be unnecessary if a family history did not exist', says director of the Centre for Clinical Practice at NICE, Professor Mark Baker.

The guideline suggests women who are at high risk of familial breast cancer should be offered preventative treatment in the form of the drugs, tamoxifen or raloxifene, provided they do not have a history of blood clots or womb cancer. Different drug combinations are to be considered dependent on whether the women are pre- or post-menopausal. Based on evidence from recent studies, the drugs would be taken for a period of five years in order to decrease the likelihood of developing breast cancer. Tamoxifen and raloxifene are both hormone therapies currently used to treat breast cancer.

In the USA, the drugs have already been approved by the Food and Drug Administration for use in preventing breast cancer. However in the UK, they are not yet licensed for use in this context. They would therefore need to be prescribed 'off label' if there is 'good evidence to support that use', reports NICE.

Other suggestions by NICE include changes to the frequency of mammogram screening, which are currently offered every three years to women over the age of 50. For women who have not had breast cancer but are aged over 40 and at high risk, NICE suggests annual mammogram screening. For women who have had breast cancer and are at high risk of developing breast cancer again, annual MRI (magnetic resonance imaging) or mammogram testing was proposed, in addition to genetic testing for known mutations.

A spokeswoman from the Department of Health told the Guardian: 'This draft guidance will help healthcare professionals support the needs of their patients and we encourage organisations or individuals with an interest to give their feedback'.

The guidelines are still under consultation and are subject to change. The final version is expected to be published in June 2013.

Breast cancer  500,000 women to be offered breast cancer drugs
Guardian |  15 January 2013
Breast cancer drugs set for preventative use
Nursing Times |  21 January 2013
Drug that prevents cancer for 20 years: Protection for thousands at high risk
Mail Online |  15 January 2013
NICE consults on new recommendations as it updates its guidelines on familial breast cancer
National Institute for Health and Clinical Excellence (press release) |  15 January 2013
Women with family history of breast cancer 'should take tamoxifen' guidance has said for the first time
Telegraph |  15 January 2013
24 April 2017 - by Dr James Heather 
Researchers have discovered a new approach to slow the rate of breast cancer tumour growth in mice...
2 December 2013 - by Dr Charlotte Warren-Gash 
Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...
30 September 2013 - by David O'Rourke 
A new genetic test that can estimate the risk of breast cancer in women returning after surgery has been approved for use in the NHS....
27 August 2013 - by Clara Salice 
In this episode of Radio 4's Inside the Ethics Committee, we hear about Rachel's strong desire for her children to be tested for an inherited disease, Li-Fraumeni syndrome...
1 October 2012 - by Dr Zara Mahmoud 
Scientists have found molecular similarities between a subtype of breast cancer and a hard-to-treat form of ovarian cancer...
10 September 2012 - by Daryl Ramai 
Women carrying mutations in their BRCA genes may be more susceptible to breast cancer if exposed to diagnostic chest X-rays before the age of 30, say scientists...
9 July 2012 - by Ruth Saunders 
Two novel gene variants linked to breast size may also also influence the risk of breast cancer, according to a study carried out by US genetics company 23andMe....
21 May 2012 - by Dr Rebecca Hill 
The genetic landscape of breast cancer is much more complicated than previously hoped, according to the authors of two analyses of multiple tumour genomes...
8 May 2012 - by Dr Kimberley Bryon-Dodd 
A link between modifications to a white blood cell gene and an increased risk of breast cancer could be the basis for a simple blood test to identify women most at risk of developing the disease...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.